» Articles » PMID: 28984313

Human Models of Migraine - Short-term Pain for Long-term Gain

Overview
Journal Nat Rev Neurol
Specialty Neurology
Date 2017 Oct 7
PMID 28984313
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is a complex disorder characterized by recurrent episodes of headache, and is one of the most prevalent and disabling neurological disorders. A key feature of migraine is that various factors can trigger an attack, and this phenomenon provides a unique opportunity to investigate disease mechanisms by experimentally inducing migraine attacks. In this Review, we summarize the existing experimental models of migraine in humans, including those that exploit nitric oxide, histamine, neuropeptide and prostaglandin signalling. We describe the development and use of these models in the discovery of molecular pathways that are responsible for initiation of migraine attacks. Combining experimental human models with advanced imaging techniques might help to identify biomarkers of migraine, and in the ongoing search for new and better migraine treatments, human models will have a key role in the discovery of future targets for more-specific and more-effective mechanism-based antimigraine drugs.

Citing Articles

Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success.

Pellesi L, Edvinsson L J Headache Pain. 2025; 26(1):22.

PMID: 39891050 PMC: 11786519. DOI: 10.1186/s10194-025-01959-8.


Cerebral blood flow and arterial responses in migraine: history and future perspectives.

Olesen J J Headache Pain. 2024; 25(1):222.

PMID: 39701954 PMC: 11656563. DOI: 10.1186/s10194-024-01903-2.


Male-female comparison of vasomotor effects of circulating hormones in human intracranial arteries.

Edvinsson J, Grubor I, Maddahi A, Edvinsson L J Headache Pain. 2024; 25(1):216.

PMID: 39663536 PMC: 11633024. DOI: 10.1186/s10194-024-01933-w.


Harnessing Miniscope Imaging in Freely Moving Animals to Unveil Migraine Pathophysiology and Validate Novel Therapeutic Strategies.

Degel C, Zitelli K, Zapata J, Nassi J, Botta P Synapse. 2024; 78(6):e70001.

PMID: 39567365 PMC: 11578939. DOI: 10.1002/syn.70001.


The Trigeminal Sensory System and Orofacial Pain.

Kim H, Chung K, Xing J, Kim H, Youn D Int J Mol Sci. 2024; 25(20).

PMID: 39457088 PMC: 11508441. DOI: 10.3390/ijms252011306.


References
1.
Thomsen L, Iversen H, Brinck T, Olesen J . Arterial supersensitivity to nitric oxide (nitroglycerin) in migraine sufferers. Cephalalgia. 1993; 13(6):395-9; discussion 376. DOI: 10.1046/j.1468-2982.1993.1306395.x. View

2.
Kruuse C, Thomsen L, Jacobsen T, Olesen J . The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab. 2002; 22(9):1124-31. DOI: 10.1097/00004647-200209000-00010. View

3.
Theoharides T, Donelan J, Kandere-Grzybowska K, Konstantinidou A . The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev. 2005; 49(1):65-76. DOI: 10.1016/j.brainresrev.2004.11.006. View

4.
Maniyar F, Sprenger T, Monteith T, Schankin C, Goadsby P . Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2013; 137(Pt 1):232-41. DOI: 10.1093/brain/awt320. View

5.
Olesen J, Diener H, Husstedt I, Goadsby P, Hall D, Meier U . Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004; 350(11):1104-10. DOI: 10.1056/NEJMoa030505. View